Cargando…
Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment
Introduction: Inflammatory bowel disease is a chronic inflammatory disorder of the gastrointestinal tract. Biologic drugs target specific molecules in the body’s immune system to control inflammation. Recent studies have suggested a potential link between their use and an increased risk of nephrolit...
Autores principales: | Alameddine, Zakaria, Abi Melhem, Racha, Dimachkie, Reem, Rabah, Hussein, Chehab, Hamed, El Khoury, Michel, Qaqish, Faris, Stefanov, Dimitre, El-Sayegh, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573832/ https://www.ncbi.nlm.nih.gov/pubmed/37834757 http://dx.doi.org/10.3390/jcm12196114 |
Ejemplares similares
-
Heparin-Induced Thrombocytopenia in Chronic Hemodialysis
Patients
por: Hamadi, Rachelle, et al.
Publicado: (2023) -
Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
por: Hamadi, Rachelle, et al.
Publicado: (2023) -
Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled trials
por: Dimachkie, Reem, et al.
Publicado: (2023) -
Nephrolithiasis in patients with inflammatory bowel disease in the community
por: Cury, Dídia Bismara, et al.
Publicado: (2013) -
Is pea our hidden allergen? An American pediatric case series
por: Abi-Melhem, Racha, et al.
Publicado: (2023)